193 related articles for article (PubMed ID: 28606234)
1. [Efficacy and safety of cyclophosphamide as a sequential immunotherapy drug for anti-N-methyl-D-aspartate receptor encephalitis in children].
Zhu WW; Liao WP; Yi YH; Song XW
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jun; 19(6):668-671. PubMed ID: 28606234
[TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children].
Wang GL; Yin F; Wang Y; Zhang WX; He F; Yang LF; Wu LW; Peng J
Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):125-130. PubMed ID: 30695887
[No Abstract] [Full Text] [Related]
3. Anti-N-methyl-d-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong.
Ho AC; Chan SH; Chan E; Wong SS; Fung ST; Cherk SW; Fung EL; Ma KH; Tsui KW; Yau EK; Wong VC
Brain Dev; 2018 Jun; 40(6):473-479. PubMed ID: 29599011
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for anti-NMDA receptor encephalitis: Experience from a single center in Taiwan.
Kong SS; Chen YJ; Su IC; Lin JJ; Chou IJ; Chou ML; Hung PC; Hsieh MY; Wang YS; Chou CC; Wang HS; Lin KL;
Pediatr Neonatol; 2019 Aug; 60(4):417-422. PubMed ID: 30449706
[TBL] [Abstract][Full Text] [Related]
5. Surgical outcomes in patients with anti-N-methyl D-aspartate receptor encephalitis with ovarian teratoma.
Dai Y; Zhang J; Ren H; Zhou X; Chen J; Cui L; Lang J; Guan H; Sun D
Am J Obstet Gynecol; 2019 Nov; 221(5):485.e1-485.e10. PubMed ID: 31128109
[TBL] [Abstract][Full Text] [Related]
6. [An 8-year-old boy with anti-NMDA receptor encephalitis, successfully treated with cyclophosphamide].
Mitani T; Ohtsuka Y; Yamamoto K; Watanabe Y; Tsuji M; Samejima K; Aida N; Sato T; Wada T; Osaka H
No To Hattatsu; 2013 Jan; 45(1):53-7. PubMed ID: 23593747
[TBL] [Abstract][Full Text] [Related]
7. Clinical manifestations, treatment outcomes, and prognostic factors of pediatric anti-NMDAR encephalitis in tertiary care hospitals: A multicenter retrospective/prospective cohort study.
Pruetarat N; Netbaramee W; Pattharathitikul S; Veeravigrom M
Brain Dev; 2019 May; 41(5):436-442. PubMed ID: 30639077
[TBL] [Abstract][Full Text] [Related]
8. Anti-N-methyl-d-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes.
Wang Y; Zhang W; Yin J; Lu Q; Yin F; He F; Peng J
J Neuroimmunol; 2017 Nov; 312():59-65. PubMed ID: 28935354
[TBL] [Abstract][Full Text] [Related]
9. [Immunotherapy strategy for 35 cases of severe anti-N-methyl-D-aspartate receptor encephalitis].
Yuan J; Peng B; Guan HZ; Huang Y; Lu Q; Ren HT; Yang XZ; Jiang N; Zhu YC; Cui LY
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(13):1035-9. PubMed ID: 27055797
[TBL] [Abstract][Full Text] [Related]
10. Refractory status epilepticus caused by anti-NMDA receptor encephalitis that markedly improved following combination therapy with rituximab and cyclophosphamide.
Kadoya M; Onoue H; Kadoya A; Ikewaki K; Kaida K
Intern Med; 2015; 54(2):209-13. PubMed ID: 25743014
[TBL] [Abstract][Full Text] [Related]
11. Childhood Anti-NMDA Receptor Encephalitis.
Suthar R; Saini AG; Sankhyan N; Sahu JK; Singhi P
Indian J Pediatr; 2016 Jul; 83(7):628-33. PubMed ID: 26801499
[TBL] [Abstract][Full Text] [Related]
12. Long-term and Strong Immunotherapy to Treat Anti-N-Methyl- D-Aspartate Receptor Encephalitis with Refractory Status Epilepticus.
Lee LH; Lu CJ
Acta Neurol Taiwan; 2016 Sep; 25(3):99-103. PubMed ID: 27854088
[TBL] [Abstract][Full Text] [Related]
13. Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care.
de Montmollin E; Demeret S; Brulé N; Conrad M; Dailler F; Lerolle N; Navellou JC; Schwebel C; Alves M; Cour M; Engrand N; Tonnelier JM; Maury E; Ruckly S; Picard G; Rogemond V; Magalhaes É; Sharshar T; Timsit JF; Honnorat J; Sonneville R;
Am J Respir Crit Care Med; 2017 Feb; 195(4):491-499. PubMed ID: 27552490
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of anti
Zheng J; Shen J; Wang A; Liu L; Xiong J; Li X; Xiao Y; Li J; Mao D; Liu L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jan; 45(1):47-54. PubMed ID: 32132297
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics and Prognosis of Severe Anti-N-methyl-D-aspartate Receptor Encephalitis Patients.
Zhang Y; Liu G; Jiang M; Chen W; He Y; Su Y
Neurocrit Care; 2018 Oct; 29(2):264-272. PubMed ID: 29651625
[TBL] [Abstract][Full Text] [Related]
16. Extended Clinical Spectrum of Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Children: A Case Series.
Goenka A; Jain V; Nariai H; Spiro A; Steinschneider M
Pediatr Neurol; 2017 Jul; 72():51-55. PubMed ID: 28506503
[TBL] [Abstract][Full Text] [Related]
17. Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients.
Armangue T; Titulaer MJ; Málaga I; Bataller L; Gabilondo I; Graus F; Dalmau J;
J Pediatr; 2013 Apr; 162(4):850-856.e2. PubMed ID: 23164315
[TBL] [Abstract][Full Text] [Related]
18. Emergency Department Presentations of Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Abe KK; Koli RL; Yamamoto LG
Pediatr Emerg Care; 2016 Feb; 32(2):107-12; quiz 113-5. PubMed ID: 26835569
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features, Therapeutic Response, and Follow-Up in Pediatric Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Experience from a Tertiary Care University Hospital in India.
Nagappa M; Bindu PS; Mahadevan A; Sinha S; Mathuranath PS; Taly AB
Neuropediatrics; 2016 Jan; 47(1):24-32. PubMed ID: 26727295
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical care of rituximab in the treatment of children with refractory anti-NMDAR encephalitis: A case report.
Wu H; Xu X; Ding Q; Zhu S; Zheng Q; Ding S; Li J; Zhao H
Medicine (Baltimore); 2023 Feb; 102(5):e32843. PubMed ID: 36749271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
